Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

chemoradiation

  • Open Access
    Evaluation of Five Prognostic Scores in Patients Receiving Chemoradiation for Primary Glioblastoma Multiforme
    OKSANA ZEMSKOVA, NATHAN Y. YU, ANASTASSIA LÖSER, JAN LEPPERT and DIRK RADES
    In Vivo July 2024, 38 (4) 1806-1813; DOI: https://doi.org/10.21873/invivo.13632
  • Open Access
    In Vitro Carbon Ion Beam and Gemcitabine Chemoradiation in a Mucoepidermoid Carcinoma Cell Line
    THOMAS SCHNEIDER, FELIX ZWICKER, PETER ERNST HUBER, JÜRGEN DEBUS and HENRIK HAUSWALD
    In Vivo September 2023, 37 (5) 1951-1959; DOI: https://doi.org/10.21873/invivo.13291
  • Open Access
    Emotional Distress Prior to Chemoradiation for Rectal or Anal Cancer
    DIRK RADES, AHMED AL-SALOOL, NATHAN Y. YU and TOBIAS BARTSCHT
    In Vivo May 2023, 37 (3) 1205-1210; DOI: https://doi.org/10.21873/invivo.13197
  • Open Access
    Increasing Seizure Activity During Radiation Treatment for High-grade Gliomas - Final Results of a Prospective Interventional Study
    DIRK RADES, JASPAR WITTELER, PETER TRILLENBERG, DENISE OLBRICH, STEVEN E. SCHILD, SØREN TVILSTED and TROELS W. KJAER
    In Vivo September 2022, 36 (5) 2308-2313; DOI: https://doi.org/10.21873/invivo.12961
  • You have access
    Definitive Radiotherapy for Older Patients Aged ≥75 Years With Localized Esophageal Cancer
    GEN SUZUKI, HIDEYA YAMAZAKI, NORIHIRO AIBE, KOJI MASUI, TAKUYA KIMOTO, DAISUKE SHIMIZU, TAKESHI NISHIMURA, AKIHIRO NAKASHIMA, KAZUTAKA MACHIDA, KANAKO KAWABATA, YOSHIAKI OTA, HITOSHI FUJIWARA, TAKESHI ISHIKAWA and KEI YAMADA
    In Vivo May 2019, 33 (3) 925-932; DOI: https://doi.org/10.21873/invivo.11560
  • You have access
    Primary Mediastinal HER2-positive Apocrine Carcinoma in Mature Teratoma Treated With Anti-HER2 Therapy and Chemoradiation
    KEIJI SUGIYAMA, AKARI IWAKOSHI, MARIKO SATOH, KAZUHIRO SHIRAISHI, KAZUKI NOZAWA, YOSHIHITO KOGURE, CHIYOE KITAGAWA, SUZUKO MORITANI, ERIKO KATOH and HIDEO SAKA
    In Vivo March 2019, 33 (2) 551-557; DOI: https://doi.org/10.21873/invivo.11509
  • You have access
    Chemoradiation Including Paclitaxel for Locally Recurrent Muscle-invasive Bladder Cancer in Elderly Patients
    LUKAS KÄSMANN, LISA MANIG, STEFAN JANSSEN and DIRK RADES
    In Vivo March 2017, 31 (2) 239-241;
In Vivo

© 2026 In Vivo

Powered by HighWire